← Back to Search

Behavioural Intervention

ARC Intervention for HIV/AIDS

N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-month period
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to address the racial disparities in HIV outcomes among Black/African American individuals by implementing an intervention called ARC (Accessibility, Responsiveness, Continuity) in outpatient HIV care clinics. The study

Who is the study for?
This trial is for HIV/AIDS clinics and their staff, focusing on improving care for racial and ethnic minority populations disproportionately affected by HIV. Clinics must be willing to implement new strategies (ARC) or continue with standard care and track patient outcomes like viral suppression and retention in care.
What is being tested?
The study tests ARC, an intervention aiming to improve organizational behavior within HIV clinics to reduce structural racism/discrimination. Clinics will either use ARC or standard care, comparing the effectiveness on patient outcomes such as viral suppression and retention over a period of up to 48 months.
What are the potential side effects?
Since this trial involves organizational interventions rather than medical treatments, it does not have traditional side effects. However, changes in clinic operations could affect staff turnover rates, job satisfaction, and potentially influence patient perceptions of discrimination.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-month period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Viral Suppression
Secondary study objectives
Retention in HIV Care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Accessibility, Responsiveness, Continuity (ARC)Experimental Treatment1 Intervention
Group II: Standard of Care (SOC)Active Control1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,725,548 Total Patients Enrolled
~821 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top